PURPOSE: To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non-small-cell lung cancer (NSCLC). 目的:为临床医师治疗III期非小细胞肺癌(NSCLC)提供循证医学建议。 METHODS: An Expert Panel of medical o...
ASCO Endorses Guideline for Molecular Testing to Select Lung Cancer Patients for EGFR and ALK Inhibitor TreatmentMatthew Stenger
[1]Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline | Journal of Clinical Oncology https://ascopubs.org/doi/10.1200/JCO.22.00825 [2]FDA Approves Libtayo:registered: (cemip...
7. 参考文献 Singh N, et al. Management of Stage IIINon-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights. JCO Oncol Pract. Published online November 18, 2024. Daly ME, et al. Management of Stage IIINSCLC Guideline Expert Panel. Management of Stage IIINon-...
Performance of comprehensive genomic profiling (CGP) versus single gene testing (SGT) in guideline-recommended biomarker selection in non-small cell lung cancer (NSCLC) 非小细胞肺癌(NSCLC)中全景变异 NGS 分析(CGP)与单基因检测(SGT)在指南推荐生物标记物选择中的性能比较 ...
Outlined below are concise summaries of studies presented at ASCO24 that focus on advancing the most effective treatment options for managing lung cancer, including Non-Small-Cell Lung Cancer (NSCLC) and Small-Cell Lung Cancer (SCLC), both early and metastatic:...
[1]Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline | Journal of Clinical Oncology https://ascopubs.org/doi/10.1200/JCO.22.00825 [2]FDA Approves Libtayo® (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-small Cell Lung...
Performance of comprehensive genomic profiling (CGP) versus single gene testing (SGT) in guideline-recommended biomarker selection in non-small cell lung cancer (NSCLC) 非小细胞肺癌(NSCLC)中全景变异 NGS 分析(CGP)与单基因检测(SGT)在指南推荐生物标记物选择中的性能比较 ...
[2]Singh N,Temin S,Baker S,Jr.,et al.Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations:ASCO Living Guideline.Journal of clinical oncology:official journal of the American Society of Clinical Oncology,2022:Jco2200825. ...
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. J Clin Oncol. doi: 10.1200/JCO.19.02748. 本文首发:医学界肿瘤频道 本文作者:张波 责任编辑:Sharon “讲出你的故事” 抗新冠肺炎故事征集中 新冠疫情、医护再上战场; ...